These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16980812)

  • 1. Exploring barriers to long-term follow-up in newborn screening programs.
    Hoff T; Hoyt A; Therrell B; Ayoob M
    Genet Med; 2006 Sep; 8(9):563-70. PubMed ID: 16980812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practices and perceptions of long-term follow-up among state newborn screening programs.
    Hoff T; Hoyt A
    Pediatrics; 2006 Jun; 117(6):1922-9. PubMed ID: 16740832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the communication practices between state newborn screening programs and the medical home.
    Kim S; Lloyd-Puryear MA; Tonniges TF
    Pediatrics; 2003 Feb; 111(2):E120-6. PubMed ID: 12563084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of pediatrician practices in retrieving statewide authorized newborn screening results.
    Desposito F; Lloyd-Puryear MA; Tonniges TF; Rhein F; Mann M
    Pediatrics; 2001 Aug; 108(2):E22. PubMed ID: 11483832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National evaluation of US newborn screening system components.
    Therrell BL; Hannon WH
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):236-45. PubMed ID: 17183567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up culture in state newborn screening programs.
    Hoff T
    Genet Med; 2008 Jun; 10(6):396-403. PubMed ID: 18496218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projected cost-effectiveness of statewide universal newborn hearing screening.
    Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
    Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic counseling and risk communication services of newborn screening programs.
    Farrell M; Certain L; Farrell P
    Arch Pediatr Adolesc Med; 2001 Feb; 155(2):120-6. PubMed ID: 11177084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up in newborn screening: A systems approach for improving health outcomes.
    Lloyd-Puryear MA; Brower A
    Genet Med; 2010 Dec; 12(12 Suppl):S256-60. PubMed ID: 21150372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance.
    Burgard P; Rupp K; Lindner M; Haege G; Rigter T; Weinreich SS; Loeber JG; Taruscio D; Vittozzi L; Cornel MC; Hoffmann GF
    J Inherit Metab Dis; 2012 Jul; 35(4):613-25. PubMed ID: 22544437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up to ensure quality care of individuals diagnosed with newborn screening conditions: early experience in New England.
    Sahai I; Eaton RB; Hale JE; Mulcahy EA; Comeau AM
    Genet Med; 2010 Dec; 12(12 Suppl):S220-7. PubMed ID: 21150368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn dried bloodspot screening: mapping the clinical and public health components and activities.
    Hinman AR; Mann MY; Singh RH;
    Genet Med; 2009 Jun; 11(6):418-24. PubMed ID: 19369886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the universal newborn hearing screening and intervention program.
    Shulman S; Besculides M; Saltzman A; Ireys H; White KR; Forsman I
    Pediatrics; 2010 Aug; 126 Suppl 1():S19-27. PubMed ID: 20679316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assuring clinical genetic services for newborns identified through U.S. newborn screening programs.
    Kaye CI; Livingston J; Canfield MA; Mann MY; Lloyd-Puryear MA; Therrell BL
    Genet Med; 2007 Aug; 9(8):518-27. PubMed ID: 17700390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-term Follow-up Study: a collaborative multi-site approach to newborn screening outcomes research.
    Wright EL; Van Hove JL; Thomas J;
    Genet Med; 2010 Dec; 12(12 Suppl):S228-41. PubMed ID: 21150369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the quality and efficiency of newborn screening programs through the use of health information technology.
    Downing GJ; Zuckerman AE; Coon C; Lloyd-Puryear MA
    Semin Perinatol; 2010 Apr; 34(2):156-62. PubMed ID: 20207265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening program practices in the United States: notification, research, and consent.
    Mandl KD; Feit S; Larson C; Kohane IS
    Pediatrics; 2002 Feb; 109(2):269-73. PubMed ID: 11826206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.